Ontario's Chief Medical Officer Report published earlier this month lays out the steps the public health sector and its partners must take over the next one to two years to be ready for infectious disease outbreaks. Interesting read: https://t.co/fktFg31TBe
Andrew Roth and Jennifer McDaniel explain the Accreditation Council for Graduate Medical Education’s adoption of the revised accreditation standards applicable to GME programs in obstetrics and gynecology. https://t.co/yd40sxnbVy
Alexis Wilpon, David Kessler and Anna Rudawski discuss Snap's recent settlement for alleged violations of the Illinois Biometric Information Privacy Act. https://t.co/0gE99O8Qlz
Will Troutman and Phil Di Tullio discuss questions related to US social compliance surrounding the Uyghur Forced Labor Prevention Act. https://t.co/WU1j4hZOfh
Webinar | United States | Please Join Susan Feigin Harris, Shea Haass and Denise Webb Glass for a discussion of the regulatory nuances, practical concerns and updates regarding litigation challenges. https://t.co/ApZJFR98rE
Jeff Margulies, Will Troutman, Lauren Shoor and Eva Yang offer an update on the latest Proposition 65 proposed rulemaking regarding short-form warnings. https://t.co/0anFTxfTTX
We are excited to announce the launch of LX Studio, our innovation-focused US subsidiary which will develop and deliver legal technology, operations and alternative legal service offerings to benefit clients beyond traditional legal advice. https://t.co/yi6pjQHtk7
In this month's Pharma 5, Los Angeles associate Jackie Karama discusses clinical trials, consumer sales, NDA regulation, the Orphan Drug Act and Learned Intermediary. https://t.co/aW3GC2v3nh
David Kessler and Susan Ross explain a third regulator's proposed consent that includes a US$500,000 fine based in part by a company’s over-retention of personal data for longer than it was needed. https://t.co/XmFKsnpprQ
Susan Feigin Harris, Mark Faccenda and Jessie Johnson discuss the US Supreme Court’s ruling on the unlawfulness of the HHS 2018–2019 reimbursement rate reduction targeting payment to 340B Drug Discount Program hospitals. https://t.co/rTKXdTfgL1
Robin Adelstein, Vic Domen and Mark Angland discuss the US Federal Trade Commission’s recent virtual workshop focused on the future of antitrust enforcement of pharmaceutical mergers. https://t.co/BN1Nnxazdl
Event | Please join us for a reception at the LondonHouse Etoile Room and Terrace immediately following the AHLA's In-House Counsel Program. https://t.co/2AZVLj6hgx
This month we recognize #NationalIndigenousHistoryMonth by celebrating the voices, culture and rich histories of all of Canada’s Indigenous peoples. It is important to reflect upon and commit to efforts towards reconciliation. #NIHM https://t.co/qXpdXP7uzO
Webinar | Eileen Fisher’s Elizabeth Richman and ethiXbase’s James Swenson will join Christopher Pelham, Julie Searle and Will Troutman in discussing the Uyghur Act and key insights into the challenges of social compliance. https://t.co/GZCRwLeRta
The pandemic forced Canadian businesses and supply chains to quickly address short-term bottlenecks, without assessing long-term #risk and liability. Join Randy Sutton and Kaitlin Smiley to hear how this disruption leads to disputes. #Disputed#Litigation https://t.co/i2prGaymco